INTRAVENOUS APPLICATION OF HELIXOR® IN GYNECOLOGICAL ONCOLOGY: IS IT SAFE?
Journal: INTERNATIONAL JOURNAL OF RESEARCH -GRANTHAALAYAH (Vol.5, No. 10)Publication Date: 2017-11-06
Authors : Yong-Il Ji;
Page : 307-312
Keywords : Intravenous Infusion of Helixor®; Mistletoe; Gynecological Cancer.;
Abstract
Mistletoe (Viscum album L.), a plant with a partially woody stem, is a semi-parasite that lives epiphytically on the branches of a variety of deciduous and coniferous trees [1]. The stems and leaves of mistletoe are used as herbal drugs, and various commercially available preparations are formulated from the crude mistletoe plant material [1]. Mistletoe extracts are complex multicomponent herbal preparations that contain various biologically active substances such as mistletoe lectins (ML), viscotoxins, amino acids, flavonoids, phenylpropanoids, triterpenes, phytosterol, alkaloids, polyalcohols, and polysaccharides, the content of which may vary depending on harvest time, species of the host tree, and manufacturing process [2] [3]. The different fractions and components exhibit varying activities including cytotoxic, antineoplastic, and immunomodulatory, which appear to be dose-dependent [4].
Other Latest Articles
- Expression of toll like receptor 4 and cluster of differentiation 14 in chronic periodontitis patients- an immunohistochemical study
- Lung Cancer of Unknown Primary Site with EGFR Mutation as Indicated by Frozen Bone Specimen
- Establishment of norms for crown angulation and inclination among Maratha population: Cross-Sectional Study
- EFFICACY STUDY OF PANCHARISHTA CHURNA IN DOOSHIVISHA WITH REFERENCE TO CONTACT DERMATITIS
- A SYSTEMATIC REVIEW TO ASSESS THE EFFECTIVENESS OF WEB BASED TRAINING VIDEO FOR LAPAROSCOPY SURGERY
Last modified: 2017-11-08 18:51:35